Richard H. Wilson

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Tim Maughan, Richard Adams, Christopher G. Smith et al. · The Lancet · 2011 · 967 citations

Medicine, Oncology, Pharmacology +12

Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors

Ruth Plummer, Christopher J. Jones, Mark R. Middleton et al. · Clinical Cancer Research · 2008 · 384 citations · Full text

Medicine, Oncology, Pharmacology +15

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

Ruth Plummer, Richard H. Wilson, Hilary Calvert et al. · British Journal of Cancer · 2011 · 381 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Acute Oxaliplatin-Induced Peripheral Nerve Hyperexcitability

Richard H. Wilson, Tanya Lehky, Rebecca R. Thomas et al. · Journal of Clinical Oncology · 2002 · 336 citations

Medicine, Neurology, Pharmacology +17

Oxaliplatin‐induced neurotoxicity: Acute hyperexcitability and chronic neuropathy

Tanya Lehky, Gregory D. Leonard, Richard H. Wilson et al. · Muscle & Nerve · 2004 · 296 citations

Medicine, Neurology, Pharmacology +13